Skip to main content
Immunologic resilience and COVID-19 survival advantage
- Lee, Grace C;
- Restrepo, Marcos I;
- Harper, Nathan;
- Manoharan, Muthu Saravanan;
- Smith, Alisha M;
- Meunier, Justin A;
- Sanchez-Reilly, Sandra;
- Ehsan, Aamir;
- Branum, Anne P;
- Winter, Caitlyn;
- Winter, Lauryn;
- Jimenez, Fabio;
- Pandranki, Lavanya;
- Carrillo, Andrew;
- Perez, Graciela L;
- Anzueto, Antonio;
- Trinh, Hanh;
- Lee, Monica;
- Hecht, Joan M;
- Martinez-Vargas, Celida;
- Sehgal, Raj T;
- Cadena, Jose;
- Walter, Elizabeth A;
- Oakman, Kimberly;
- Benavides, Raymond;
- Pugh, Jacqueline A;
- Team, South Texas Veterans Health Care System COVID-19;
- Abdalla, Mohamed I;
- Adams, Sandra G;
- Agnew, Joseph;
- Ali, Saleem;
- Barker, Jennifer;
- Birdwell, Angela;
- Bradford, Stephen;
- Briggs, Heather;
- Corral, Judith Marin;
- Dacus, Jennifer J;
- Danaher, Patrick J;
- DePaul, Scott A;
- Dickerson, Jill;
- Doanne, Jollynn;
- Elbel, Samantha;
- Escamilla, Corina;
- Farrar, Robert;
- Feldman, David;
- Flynn, Julianne;
- Ford, Delvina;
- Foy, Joanna D;
- Freeman, Megan;
- Galley, Samantha;
- Garza, Maritza;
- Gilman, Sherraine;
- Gomez, Jennifer;
- Goyal, Varun K;
- Grassmuck, Sally;
- Hanson, Joshua;
- Harris, Brande;
- Hastings, Gabrielyd;
- Haywood, Audrey;
- Hinojosa, Cecilia;
- Ho, Tony T;
- Hopkins, Teri;
- Jewell, Pamela;
- Johnson, Thomas B;
- Kotogiannes, Vasiliki;
- Lawler, Austin C;
- Lester, Chadwick S;
- Levine, Stephanie M;
- Lewis, Haidee V;
- Louder, Angel;
- Mainor, Charmaine;
- Maldonado, Rachel;
- Martinez, Yvette;
- McElligott, Neil;
- Medlin, Laura;
- Mireles, Myra;
- Morneau, Kathleen;
- Munro, Samuel B;
- Nambiar, Anoop;
- Nassery, Daniel;
- Nathanson, Robert;
- O’Rorke, Jane;
- Padgett, Cheryl;
- Pascual-Guardia, Sergi;
- Patterson, Marisa;
- Perez, Rogelio;
- Phillips, Robert E;
- Polk, Patrick B;
- Pomager, Michael A;
- Preston, Kristy J;
- Proud, Kevin C;
- Rangel, Michelle;
- Ratcliffe, Temple A;
- Reichelderfer, Renee L;
- Renz, Evan M;
- Ross, Jeanette;
- Rudd, Teresa;
- Sanchez, Maria E;
- Sanders, Tammy;
- Schindler, Kevin C;
- Schmit, David;
- Solorzano, Claudio;
- Soni, Nilam;
- Tam, Win S;
- Tovar, Edward J;
- Tyler, Anna R;
- Vasquez, Anjuli;
- Veloso, Maria C;
- Venticinque, Steven G;
- Villalpando, Jorge A;
- Villanueva, Melissa;
- Villegas, Lauren;
- Wallace, Andrew;
- Wang, Emily;
- Williamson, Andreia;
- Velasquez, Sadie A Trammell;
- Yunes, Andrea;
- Zentner, Katharine H;
- Letendre, Scott;
- Steri, Maristella;
- Orrù, Valeria;
- Fiorillo, Edoardo;
- Cucca, Francesco;
- Moreira, Alvaro G;
- Zhang, Nu;
- Leadbetter, Elizabeth;
- Agan, Brian K;
- Richman, Douglas D;
- He, Weijing;
- Clark, Robert A;
- Okulicz, Jason F;
- Ahuja, Sunil K
- et al.
Published Web Location
https://pubmed.ncbi.nlm.nih.gov/34508765/No data is associated with this publication.
Abstract
Background
The risk of severe coronavirus disease 2019 (COVID-19) varies significantly among persons of similar age and is higher in males. Age-independent, sex-biased differences in susceptibility to severe COVID-19 may be ascribable to deficits in a sexually dimorphic protective attribute that we termed immunologic resilience (IR).Objective
We sought to examine whether deficits in IR that antedate or are induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection independently predict COVID-19 mortality.Methods
IR levels were quantified with 2 novel metrics: immune health grades (IHG-I [best] to IHG-IV) to gauge CD8+ and CD4+ T-cell count equilibrium, and blood gene expression signatures. IR metrics were examined in a prospective COVID-19 cohort (n = 522); primary outcome was 30-day mortality. Associations of IR metrics with outcomes in non-COVID-19 cohorts (n = 13,461) provided the framework for linking pre-COVID-19 IR status to IR during COVID-19, as well as to COVID-19 outcomes.Results
IHG-I, tracking high-grade equilibrium between CD8+ and CD4+ T-cell counts, was the most common grade (73%) among healthy adults, particularly in females. SARS-CoV-2 infection was associated with underrepresentation of IHG-I (21%) versus overrepresentation (77%) of IHG-II or IHG-IV, especially in males versus females (P < .01). Presentation with IHG-I was associated with 88% lower mortality, after controlling for age and sex; reduced risk of hospitalization and respiratory failure; lower plasma IL-6 levels; rapid clearance of nasopharyngeal SARS-CoV-2 burden; and gene expression signatures correlating with survival that signify immunocompetence and controlled inflammation. In non-COVID-19 cohorts, IR-preserving metrics were associated with resistance to progressive influenza or HIV infection, as well as lower 9-year mortality in the Framingham Heart Study, especially in females.Conclusions
Preservation of immunocompetence with controlled inflammation during antigenic challenges is a hallmark of IR and associates with longevity and AIDS resistance. Independent of age, a male-biased proclivity to degrade IR before and/or during SARS-CoV-2 infection predisposes to severe COVID-19.Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.